PRESS RELEASE published on 02/20/2024 at 09:21, 2 years 4 months ago Original-Research: ABO Wind AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research bestätigt Kaufempfehlung für ABO Wind AG und erhöht Kursziel auf 110,00 Euro. Unternehmen erreicht Rekordergebnis in 2023 und erwartet weiteres Wachstum durch regulatorische Änderungen und Preisrückgang für Solarmodule Kursziel Kaufempfehlung ABO Wind AG Rekordergebnis Regulatorische Änderungen
PRESS RELEASE published on 02/16/2024 at 10:17, 2 years 4 months ago EQS-Adhoc: ABO Wind AG raises forecast for 2023 annual result ABO Wind AG raises 2023 annual result forecast to 27.3 million euros, up from previous range of 22 to 26 million euros. Annual financial statements to be published on March 14 Financial Statements 2023 Forecast ABO Wind AG Annual Result
PRESS RELEASE published on 11/02/2023 at 09:17, 2 years 7 months ago Original-Research: ABO Wind AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 10/30/2023 at 16:19, 2 years 7 months ago ABO Wind AG: 87 percent support change of legal form to ABO Energy KGaA
PRESS RELEASE published on 10/17/2023 at 11:55, 2 years 8 months ago ABO Wind AG: Hydrogen project enters the next phase
PRESS RELEASE published on 10/16/2023 at 11:04, 2 years 8 months ago ABO Wind has become leading wind project developer in Finland
PRESS RELEASE published on 09/07/2023 at 09:22, 2 years 9 months ago Original-Research: ABO Wind AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 09/01/2023 at 12:43, 2 years 9 months ago ABO Wind AG: ABO Wind secures lands for Toqlukuti’k Wind and Hydrogen Project in Newfoundland and Labrador
PRESS RELEASE published on 08/31/2023 at 11:13, 2 years 9 months ago ABO Wind AG: Successful first half year reported
PRESS RELEASE published on 06/09/2023 at 11:26, 3 years ago Original-Research: ABO Wind AG (von First Berlin Equity Research GmbH): Buy
Published on 06/26/2026 at 14:05, 1 hour 57 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 2 hours 2 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 3 hours 2 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 3 hours 17 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 32 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 38 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 15:23, 39 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 07:00, 9 hours 2 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 9 hours 2 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
